Dr. Turner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 320
Rochester, NY 14642Phone+1 585-275-2222Fax+1 585-273-1222
Education & Training
- University of RochesterResidency, Internal Medicine, 2012 - 2015
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2013
Certifications & Licensure
- NY State Medical License 2015 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of RP1 Monotherapy and RP1 in Combination With Nivolumab Start of enrollment: 2017 Sep 20
- Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma Start of enrollment: 2019 Jul 24
Roles: Contact
Publications & Presentations
PubMed
- 51 citationsCentral Role of IFNγ–Indoleamine 2,3-Dioxygenase Axis in Regulation of Interleukin-12–Mediated Antitumor ImmunityTao Gu, Rachael B. Rowswell-Turner, Mehmet O. Kilinc, Nejat K. Egilmez
Cancer Research. 2010-01-01 - 14 citationsHE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.Rachael B. Rowswell-Turner, Rakesh K. Singh, Anze Urh, Naohiro Yano, Kyu Kwang Kim
Journal of Immunology. 2021-04-26 - 26 citationsDichotomous Effects of IFN-γ on Dendritic Cell Function Determine the Extent of IL-12–Driven Antitumor T Cell ImmunityJamie L. Harden, Tao Gu, Mehmet O. Kilinc, Rachael B. Rowswell-Turner, Lauren P. Virtuoso
Journal of Immunology. 2011-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: